 |
Partners' Directory |
| Home Join the Partnership Login | |
View the Partner Information
Organization Contact Information | |
| Organization Name: | ALVitae Pharmaceuticals |
| Organization Street 1: | 2440 Camino Ramon, Suite 150 |
| Organization Street 2: | |
| Organization City: | San Ramon |
| Organization Province: | CA |
| Organization Post Code: | 94583 |
| Organization Country: | United States of America |
| Organization Phone: | 19254135670 |
| Organization Email: | alin@alvitae.com |
| Organization Web Site: | http://www.alvitae.com |
Focal Point Contact Information | |
| Focal Point Salutation: | Dr |
| Focal Point First Name: | Augustine |
| Focal Point Last Name: | Lin |
| Focal Point Title: | President and CEO |
| Focal Point Email: | alin@alvitae.com |
Stop TB Partner Information | |
| Organization Type: | Corporate Sector (Health) |
| Organization Description: | ALVitae Pharmaceuticals is an emerging biotech company located in San Francisco Bay Area, California, USA with its business focus on research and development of products for improving early detection and treatment of diseases with unmet medical needs, especially for infectious diseases. The company had been developing low-cost, easy-to-operate products for molecular detection of TB with much improved sensitivity and specificity based on its propriotory patented technologies. The products are able to detect as little as one copy of TB in the testing specimen. |
| How did you hear about the Stop TB Partnership: | Unknown |
| Why do you wish join the Stop TB Partnership: | Unknown |
| What TB activity\ies are you mainly involved in: | Unknown |
| Which Working Group(s) will you participate in: | Unknown |
| No of staff who are directly involved with TB: | Unknown |
| Which country are you based in: | United States of America |
| Which country/ies do you do operate in: | Unknown |
| Which WHO region is the main focus of your work: | American |
| Are you a member of a Stop TB national partnership: | Unknown |
|
Declaration of interests No conflicts of interest were delacred. | |